Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03824366 · ClinicalTrials.gov registry record · NA

Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT03824366: Completed NA study, sponsored by Washington University School of Medicine.

NCT03824366 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03824366, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This proposed study is unique in that patients will not undergo computed tomography (CT) simulation at any point during their treatment course and will instead have same-session magnetic resonance (MR)-only simulation and treatment planning, on-table, using the adaptive radiotherapy (ART) workflow. In this manner, patients requiring urgent treatment could initiate treatment as early as the day of initial radiation oncology consultation.

Interventions

  • RADIATION Radiation therapy
  • DEVICE Volumetric MR imaging

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2019-04-23
Est. Completion 2022-01-14
Phase NA

What the finished NCT03824366 record still lists

NCT03824366 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Radiation therapy is the first listed.

NCT03824366 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03824366 about?

NCT03824366 is a clinical study titled "Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy". This proposed study is unique in that patients will not undergo computed tomography (CT) simulation at any point during their treatment course and will instead have same-session magnetic resonance (MR)-only simulation and treatment planning, on-table, using the adaptive radiotherapy (ART) workflow. ...

What is the current status of trial NCT03824366?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-04-23. Estimated completion is 2022-01-14.

What interventions are being tested in trial NCT03824366?

The interventions under investigation include: Radiation therapy (RADIATION), Volumetric MR imaging (DEVICE).

Who is sponsoring clinical trial NCT03824366?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03824366's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03824366, the US trial registry maintained by the National Library of Medicine. NCT03824366 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.